DK3242869T3 - Sammensætninger og fremgangsmåder til behanding af inflammation og smerte - Google Patents

Sammensætninger og fremgangsmåder til behanding af inflammation og smerte Download PDF

Info

Publication number
DK3242869T3
DK3242869T3 DK15745569.2T DK15745569T DK3242869T3 DK 3242869 T3 DK3242869 T3 DK 3242869T3 DK 15745569 T DK15745569 T DK 15745569T DK 3242869 T3 DK3242869 T3 DK 3242869T3
Authority
DK
Denmark
Prior art keywords
pain
compositions
methods
treating inflammation
inflammation
Prior art date
Application number
DK15745569.2T
Other languages
English (en)
Inventor
Mahesha Kandula
Original Assignee
Cellix Bio Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Private Ltd filed Critical Cellix Bio Private Ltd
Application granted granted Critical
Publication of DK3242869T3 publication Critical patent/DK3242869T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126Acids containing more than four carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03Monocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03Monocarboxylic acids
    • C07C57/12Straight chain carboxylic acids containing eighteen carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
DK15745569.2T 2015-01-06 2015-05-07 Sammensætninger og fremgangsmåder til behanding af inflammation og smerte DK3242869T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN89CH2015 2015-01-06
PCT/IN2015/000199 WO2016110865A1 (en) 2015-01-06 2015-05-07 Compositions and methods for the treatment of inflammation and pain

Publications (1)

Publication Number Publication Date
DK3242869T3 true DK3242869T3 (da) 2022-01-31

Family

ID=53776913

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15745569.2T DK3242869T3 (da) 2015-01-06 2015-05-07 Sammensætninger og fremgangsmåder til behanding af inflammation og smerte

Country Status (9)

Country Link
US (3) US10227301B2 (da)
EP (1) EP3242869B1 (da)
JP (3) JP6679616B2 (da)
CN (2) CN110845355A (da)
CA (1) CA2973178C (da)
DK (1) DK3242869T3 (da)
ES (1) ES2905771T3 (da)
SG (1) SG11201705524SA (da)
WO (1) WO2016110865A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110845355A (zh) * 2015-01-06 2020-02-28 塞尔利克斯生物私人有限公司 用于治疗炎症和疼痛的组合物和方法
MX2019007713A (es) * 2016-12-26 2019-10-30 Cellix Bio Private Ltd Composiciones y metodos para el tratamiento del dolor cronico.
CN109896992A (zh) * 2017-12-08 2019-06-18 武汉软件工程职业学院 制备离子液体的方法及其应用
US20210228556A1 (en) * 2018-05-08 2021-07-29 University Of Connecticut Long-acting local anesthetic formulation
WO2023073574A1 (en) * 2021-10-28 2023-05-04 Cellix Bio Private Limited Process for the preparation of piperidine carboxamides salt forms and thereof

Family Cites Families (163)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2807644A (en) 1954-08-20 1957-09-24 Parke Davis & Co Pantethine inhibitors
DE1205972B (de) 1963-08-20 1965-12-02 Merck Ag E Verfahren zur Herstellung eines Liponsaeure-derivates
FR1434130A (fr) * 1964-07-31 1966-04-08 Dausse Lab Sels de l'acide nu-cyclohexylsulfamique et leur procédé de préparation
US4011342A (en) 1971-06-02 1977-03-08 Seperic Method and composition for the treatment of hypertension with ortho-disubstituted arylguanidines
GB1356470A (en) 1971-06-02 1974-06-12 Seperic Ortho-disubstituted aryl-guanidines process for their preparation and applications thereof
AU514991B2 (en) 1976-05-26 1981-03-12 Commonwealth Of Australia, The Pharmaceutical compositions containing antiinflammatory analgesic compounds
JPS5412340A (en) 1977-06-27 1979-01-30 Daito Koeki Process for preparing phenylacetate derivative
JPS5677259A (en) 1979-11-29 1981-06-25 Nippon Chemiphar Co Ltd N-pyridoxyl 5,8,11,14,17-eicosapentaenoic acid amide, and its preparation
JPS57500432A (da) 1980-03-20 1982-03-11
US4404366A (en) 1980-05-06 1983-09-13 Miles Laboratories, Inc. Beta-galactosyl-umbelliferone-labeled hapten conjugates
US4412992A (en) 1980-07-21 1983-11-01 Biorex Laboratories Limited 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
US4440763A (en) 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
IT1190727B (it) 1982-03-10 1988-02-24 Ausonia Farma Srl Composto ad attivita' analgesica,antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche
FR2528038B2 (fr) 1982-06-04 1985-08-09 Lafon Labor Derives de benzhydrylsulfinylacetamide et leur utilisation en therapeutique
US4564628A (en) 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
US5104887A (en) 1983-02-04 1992-04-14 University Of Iowa Research Foundation Topical ophthalmic imino substituted 2-imino-3-methyl-delta4-1,3,4-thiadiazoline-5-sulfonamides carbonic anhydrase inhibitors
AU560367B2 (en) 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
JPS6089474A (ja) 1983-10-20 1985-05-20 Toyo Pharma- Kk モルフイナン誘導体,その製造方法,及び該化合物を含有する抗腫瘍剤
IL73293A (en) 1983-11-04 1988-02-29 Abbott Lab Methyl 2-(alkanamidoalkylsulfonic)ethylthiophosphonate derivatives
IT1213132B (it) 1984-02-02 1989-12-14 Yason Srl Agente antibroncopneumopatico.
US4550109A (en) 1984-05-31 1985-10-29 The Board Of Regents, The University Of Texas System Lipoidal biopterin compounds
JPS61277618A (ja) 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
YU213587A (en) 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US4873259A (en) 1987-06-10 1989-10-10 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5102870A (en) 1989-04-14 1992-04-07 Schering Ag Treatment and prevention of oral mucositis with growth factors
EP0421441B1 (en) 1989-10-06 1995-01-25 Fujirebio Inc. Pantothenic acid derivatives
US5242937A (en) 1990-03-19 1993-09-07 Research Corporation Technologies, Inc. Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors
IT1248702B (it) 1990-06-06 1995-01-26 Yason Srl Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche
FR2699077B1 (fr) 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2707637B1 (fr) 1993-06-30 1995-10-06 Lafon Labor Nouveaux dérivés d'acétamide, leur procédé de préparation et leur utilisation en thérapeutique.
CA2183562A1 (en) 1994-02-18 1995-08-24 J. Peter Klein Intracellular signalling mediators
SE9401727D0 (sv) 1994-05-18 1994-05-18 Astra Ab New compounds I
FR2722199B3 (fr) 1994-07-11 1996-09-06 Univ Picardie Jules Verne Etab Derives de l'acide valproique et leurs applications comme medicaments
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
NZ334389A (en) 1996-08-28 2001-05-25 Ube Industries Cyclic amine derivatives
PL334516A1 (en) 1996-11-22 2000-02-28 Elan Pharm Inc N-(aryl/heteroaryl/alkylacetyl)amino cid amides, pharmaceutic agent containing them and method of inhibiting eduction and/or synthesis of beta-amyloid peptide using such compounds
US6414008B1 (en) 1997-04-29 2002-07-02 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions
GB9710351D0 (en) 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
ATE535232T1 (de) * 1997-09-18 2011-12-15 Pacira Pharmaceuticals Inc Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
NZ333474A (en) 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
MXPA00008439A (es) 1998-02-27 2002-04-24 Sankyo Co Compuestos amino ciclicos..
JP3761324B2 (ja) 1998-05-15 2006-03-29 ヤンマー農機株式会社 乗用田植機
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
CA2368083A1 (en) 1999-04-06 2000-10-12 Sepracor Inc. Derivatives of venlafaxine and methods of preparing and using the same
US6262118B1 (en) 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
CA2385990A1 (en) 1999-09-29 2001-04-05 The Procter & Gamble Company Compositions having improved stability
US20020049155A1 (en) 2000-05-31 2002-04-25 Hogenkamp Henricus P.C. Cobalamin compounds useful as cardiovascular agents and as imaging agents
US6429223B1 (en) 2000-06-23 2002-08-06 Medinox, Inc. Modified forms of pharmacologically active agents and uses therefor
WO2002009769A2 (en) 2000-07-27 2002-02-07 Rutgers, The State University Of New Jersey Therapeutic azo-compounds for drug delivery
KR100810930B1 (ko) 2000-10-24 2008-03-10 아지노모토 가부시키가이샤 나테글리니드 b형 결정의 제조방법
DE10103506A1 (de) 2001-01-26 2002-08-14 Ingo S Neu Pharmazeutische Zusammensetzung zur Behandlung von Multiple Sklerose
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
FR2827517B1 (fr) 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
AU2002326806B2 (en) 2001-08-29 2007-07-19 Endo Pharmaceuticals, Inc. Analgetic pyrroline derivatives
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
US20040010038A1 (en) 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
US20030220344A1 (en) 2002-04-04 2003-11-27 Luiz Belardinelli Method of treating arrhythmias
JP4615866B2 (ja) 2002-04-15 2011-01-19 ノバルティス アーゲー N−(トランス−4−イソプロピルシクロヘキシルカルボニル)−d−フェニルアラニンの結晶形
MXPA04010170A (es) 2002-04-16 2005-02-03 Fujisawa Pharmaceutical Co Medicamento para prevenir y/o tratar el rechazo cronico.
US7060725B2 (en) 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
GB0223224D0 (en) 2002-10-07 2002-11-13 Novartis Ag Organic compounds
US7101912B2 (en) 2002-12-06 2006-09-05 Xenoport, Inc. Carbidopa prodrugs and derivatives, and compositions and uses thereof
CA2800237C (en) 2002-12-19 2016-05-17 The Scripps Research Institute Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
ES2310715T3 (es) 2003-02-14 2009-01-16 Pierre Fabre Medicament Uso del enantiomero (1s,2r) del milnacipran para la preparacion de un medicamento.
UA81657C2 (ru) 2003-03-04 2008-01-25 Орто-Макнейл Фармасьютикел, Инк. Способ получения противосудорожных производных топирамата
US20060159746A1 (en) 2003-03-18 2006-07-20 Troup John P Compositions comprising fatty acids and amino acids
EP1643999B8 (en) 2003-06-20 2012-03-14 NephroGenex, Inc. Pyridoxamine for use in the treatment of diabetic nephropathy in type ii diabetes
JP2007510621A (ja) 2003-07-29 2007-04-26 シグニチャー アールアンドディー ホールディングス,エルエルシー. アミノ酸プロドラッグ
MXPA06004088A (es) 2003-10-14 2006-06-27 Xenoport Inc Forma cristalina de un analogo del acido gamma-aminobutirico.
US7470435B2 (en) 2003-11-17 2008-12-30 Andrx Pharmaceuticals, Llc Extended release venlafaxine formulation
CA2547472A1 (en) 2003-11-28 2005-06-09 Sankyo Company Limited Cyclic amine derivative having heteroaryl ring
DE10361259A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes
CN1248690C (zh) 2004-03-25 2006-04-05 华中师范大学 一种治疗心血管疾病含盐酸雷诺嗪的口服制剂
CA2561672A1 (en) 2004-04-07 2005-12-08 The University Of Georgia Research Foundation, Inc. Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
JP5250257B2 (ja) 2004-04-29 2013-07-31 テイコク ファーマ ユーエスエー インコーポレーテッド メサドン局所組成物およびその使用方法
CN1672678A (zh) 2004-05-03 2005-09-28 深圳微芯生物科技有限责任公司 预防和治疗前列腺疾病的长链脂肪酸天然活性成分的分离、提取和药用制剂的制备和应用
CN101023056B (zh) 2004-06-04 2011-05-25 克塞诺波特公司 左旋多巴前药、和组合物及其应用
CN100455560C (zh) 2004-06-09 2009-01-28 中国人民解放军军事医学科学院放射医学研究所 含长链脂肪酰基取代的文拉法辛前体药物及其制备方法和用途
WO2006075123A1 (en) 2005-01-14 2006-07-20 Camurus Ab Topical bioadhesive formulations
EP1863433A4 (en) 2005-03-18 2009-09-09 Ripped Formulations Ltd COMPOSITIONS AND METHODS FOR INCREASING METABOLISM, HEAT GENERATION AND / OR MUSCLE EDUCATION
CN101171005A (zh) 2005-05-11 2008-04-30 尼科梅德有限责任公司 Pde4抑制剂罗氟司特与四氢生物蝶呤衍生物的组合
DE102005022276A1 (de) 2005-05-13 2006-11-16 Ellneuroxx Ltd. Derivate von Dihydroxyphenylalanin
WO2006125293A1 (en) 2005-05-27 2006-11-30 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
JPWO2006126676A1 (ja) 2005-05-27 2008-12-25 第一三共株式会社 置換アルキル基を有する環状アミン誘導体
ES2387195T3 (es) * 2005-05-27 2012-09-17 Royer Biomedical, Inc. Matrices de polímero y métodos de fabricación y uso de las mismas
US20060270635A1 (en) 2005-05-27 2006-11-30 Wallace John L Derivatives of 4- or 5-aminosalicylic acid
US20080262053A1 (en) 2005-10-18 2008-10-23 Juergen Reess Use of Pramipexole for Treating Moderate to Severe Restless Legs Syndrome (Rls)
EP1980271A4 (en) 2006-01-27 2012-04-25 Asahi Kasei Pharma Corp MEDICINE FOR TRANSNASAL ADMINISTRATION
US20070259930A1 (en) 2006-04-10 2007-11-08 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
EP1870395A1 (en) 2006-06-19 2007-12-26 KRKA, D.D., Novo Mesto Process for preparation of o-desmethylvenlafaxine and its analogue
EP2046121B1 (en) * 2006-07-14 2012-08-22 Stiefel Research Australia Pty Ltd Fatty acid pharmaceutical foam
US7943666B2 (en) 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
US7645767B2 (en) 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
TW200817048A (en) 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
RU2491068C2 (ru) 2006-12-14 2013-08-27 Нопп Ньюросайенсиз, Инк. Композиции и способы применения (r)-прамипексола
CN100573950C (zh) 2006-12-14 2009-12-23 财团法人工业技术研究院 相变存储装置及其制造方法
WO2008079404A2 (en) 2006-12-22 2008-07-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
JP2010515747A (ja) 2007-01-12 2010-05-13 ビオマリン プハルマセウトイカル インコーポレイテッド テトラヒドロビオプテリンプロドラッグ
ES2319024B1 (es) 2007-02-13 2009-12-11 Quimica Sintetica, S.A. Procedimiento para la obtencion de entacapona sustancialmente libre de isomero z, sus intermedios de sintesis y nueva forma cristalina.
RU2454409C2 (ru) 2007-03-14 2012-06-27 Нопп Ньюросайенсиз, Инк. Синтез хирально очищенных замещенных бензотиазолдиаминов
ATE546449T1 (de) 2007-05-01 2012-03-15 Concert Pharmaceuticals Inc Morphinanverbindungen
EP1997493A1 (en) 2007-05-28 2008-12-03 Laboratorios del Dr. Esteve S.A. Combination of a 5-HT7 receptor ligand and an opioid receptor ligand
CA2690776A1 (en) 2007-06-22 2008-12-31 Gluconova Llc Halide-free glucosamine-acidic drug complexes
US20090075942A1 (en) 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched fosamprenavir
CN101390854A (zh) 2007-09-21 2009-03-25 北京德众万全药物技术开发有限公司 一种含有利鲁唑的药用组合物
US20090093547A1 (en) * 2007-10-09 2009-04-09 Sciele Pharma, Inc. Compositions and Methods for Treating Premature Ejaculation
WO2009056791A1 (en) 2007-11-02 2009-05-07 Pliva Hrvatska D.O.O. Processes for preparing pharmaceutical compounds
WO2009061934A1 (en) 2007-11-06 2009-05-14 Xenoport, Inc. Use of prodrugs of gaba b agonists for treating neuropathic and musculoskeletal pain
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US8623387B2 (en) * 2007-11-22 2014-01-07 Medrx Co., Ltd. External preparation composition comprising fatty acid-based ionic liquid as active ingredient
CN101186583B (zh) 2007-12-20 2011-05-11 吉林大学 2-(2-(2,6-二氯苯基氨基)苯基)醋酸甲酯及其合成方法及其应用
WO2009100441A2 (en) * 2008-02-08 2009-08-13 Impax Laboratories, Inc. Depot formulations
US20100081713A1 (en) 2008-03-19 2010-04-01 CombinatoRx, (Singapore) Pte. Ltd. Compositions and methods for treating viral infections
CN102512405B (zh) 2008-04-30 2015-08-05 上海医药工业研究院 一类长链脂肪酸衍生物或含其的植物提取物在制备抑制芳香化酶活性的药物中的应用
KR100990949B1 (ko) 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
CN102149673B (zh) 2008-07-08 2014-07-09 凯特贝希制药公司 脂肪酸乙酰化的水杨酸酯及其用途
JP5544544B2 (ja) * 2008-08-05 2014-07-09 株式会社 メドレックス 塩基性薬効成分の脂肪酸塩、安息香酸塩を含有する外用剤とその製造方法
US8148414B2 (en) 2008-08-19 2012-04-03 Xenoport, Inc. Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
NZ591326A (en) 2008-08-22 2012-12-21 Wockhardt Research Center An extended release pharmaceutical composition of entacapone or salts thereof
EP2165706A1 (en) 2008-09-18 2010-03-24 BioAlliance Pharma Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
WO2010073124A2 (en) 2008-12-26 2010-07-01 Actavis Group Ptc Ehf Processes for preparing highly pure rotigotine or a pharmaceutically acceptable salt thereof
BRPI0901298A2 (pt) 2009-04-06 2011-01-04 Ems Sa derivados ftalimìdicos de compostos antiinflamatórios não-esteróide e/ou moduladores de tnf-(alfa), processo de sua obtenção, composições farmacêuticas contendo os mesmos e seus usos no tratamento de doenças inflamatórias
CN101559077A (zh) * 2009-04-16 2009-10-21 官培龙 一种口腔炎症性疾病止痛用含漱液
MY198422A (en) 2009-04-29 2023-08-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2010147666A1 (en) 2009-06-19 2010-12-23 Memorial Sloan-Kettering Cancer Center Compounds useful as carbonic anhydrase modulators and uses thereof
JP2013501733A (ja) 2009-08-10 2013-01-17 ビーエイチアイ リミテッド パートナーシップ 1,3−プロパンジスルホン酸を送達するための方法、化合物、および組成物
CN102002053A (zh) 2009-09-02 2011-04-06 陕西合成药业有限公司 用于治疗的四氢噻吩并吡啶衍生物
CN101717392A (zh) 2009-10-09 2010-06-02 苏州凯达生物医药技术有限公司 一种制备罗替戈汀及其衍生物的方法
CN102050815B (zh) 2009-11-06 2014-04-02 北京美倍他药物研究有限公司 作为前药的达比加群的酯衍生物
CN101724934B (zh) 2009-11-10 2012-07-04 东华大学 一种用于治疗皮肤炎症和疼痛的药用纤维及其制备和应用
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
WO2011085211A1 (en) 2010-01-08 2011-07-14 Catabasis Pharmaceuticals, Inc. Fatty acid fumarate derivatives and their uses
US9062094B2 (en) 2010-01-22 2015-06-23 Ascendis Pharma As Dipeptide-based prodrug linkers for aliphatic amine-containing drugs
RU2436772C2 (ru) 2010-01-28 2011-12-20 Закрытое акционерное общество "НПК ЭХО" 4[(4'-никотиноиламино)бутироиламино]бутановая кислота, проявляющая ноотропную активность, и способ ее получения
US20130190327A1 (en) 2010-02-26 2013-07-25 Catabasis Pharmaceuticals Inc Bis-fatty acid conjugates and their uses
JP5412340B2 (ja) 2010-03-19 2014-02-12 本田技研工業株式会社 車両の視認窓
CA2801336C (en) 2010-06-08 2020-01-28 Mahesh Kandula Cysteamine derivatives and their use in the treatment of nash
MX337454B (es) 2010-07-12 2016-03-07 Boehringer Ingelheim Int Composicion acuosa que contiene bromhexina.
AR082499A1 (es) 2010-08-23 2012-12-12 Gruenenthal Gmbh Compuestos utiles para trastornos del sistema nervioso, inflamatorios, estomacales y como analgesicos
WO2012027543A1 (en) 2010-08-25 2012-03-01 Teva Pharmaceuticals Usa, Inc. Solid state forms of dabigatran etexilate, dabigatran etexilate mesylate and processes for preparation thereof
CN101921245B (zh) 2010-08-30 2012-04-18 中国人民解放军军事医学科学院卫生学环境医学研究所 抑制碳酸酐酶ⅱ的磺胺类化合物及合成方法与用途
HUE034890T2 (hu) 2010-10-29 2018-03-28 Algiax Pharmaceuticals Gmbh Malononitrilaminok alkalmazása neuropathiás fájdalomban
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
WO2012115695A1 (en) 2011-02-25 2012-08-30 Catabasis Pharmaceuticals, Inc. Bis-fatty acid conjugates and their uses
LT2701681T (lt) * 2011-04-29 2016-12-12 Moberg Pharma Ab Farmacinės kompozicijos, apimančios vietinį anestetiką, tokį kaip bupivakainas, skirts vietiniam įvedimui į burną arba į gerklę
WO2013008182A1 (en) 2011-07-10 2013-01-17 Mahesh Kandula Prodrugs of gaba analogs
CN102336767A (zh) 2011-07-11 2012-02-01 华东理工大学 制备高纯度手性α-取代-6,7-二氢噻吩并[3,2-c]吡啶衍生物的方法
WO2013017974A1 (en) 2011-07-30 2013-02-07 Mahesh Kandula Compositions and methods for the treatment of neuromuscular disorders and neurodegenerative diseases
WO2013024376A1 (en) 2011-08-16 2013-02-21 Mahesh Kandula Compositions and methods for the treatment of atherothrombosis
WO2013027150A1 (en) 2011-08-21 2013-02-28 Mahesh Kandula Compositions and methods for the treatment of parkinson's disease
CN102633799B (zh) 2012-04-10 2014-06-25 凯莱英医药集团(天津)股份有限公司 一种从消旋体中间体拆分路线合成二盐酸沙丙蝶呤的方法
WO2013167993A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurological degenerative disorders
US20150133533A1 (en) 2012-05-08 2015-05-14 Mahesh Kandula Compositions and methods for the treatment of cough
WO2013168022A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treating atherothrombosis
CN104603090A (zh) 2012-05-10 2015-05-06 塞利克斯比奥私人有限公司 治疗代谢综合征的组合物和方法
CN104583182A (zh) 2012-05-23 2015-04-29 塞利克斯比奥私人有限公司 用于治疗粘膜炎的组合物和方法
JPWO2014061497A1 (ja) * 2012-10-16 2016-09-05 コニカミノルタ株式会社 フィルムミラー及び太陽熱発電用反射装置
WO2014091384A2 (en) * 2012-12-12 2014-06-19 Mahesh Kandula Compositions and methods for the treatment of mucositis
WO2014160026A2 (en) * 2013-03-14 2014-10-02 Endo Pharmaceuticals Solutions Inc. Implantable drug delivery compositions comprising sugar-based sorption enhancers and methods of treatment thereof
WO2014174425A2 (en) 2013-04-24 2014-10-30 Mahesh Kandula Compositions and methods for the treatment of orthostasis and neurological diseases
WO2014195961A1 (en) 2013-06-04 2014-12-11 Mahesh Kandula Compositions and methods for the treatment of diabetes and pre-diabetes
CN110845355A (zh) * 2015-01-06 2020-02-28 塞尔利克斯生物私人有限公司 用于治疗炎症和疼痛的组合物和方法

Also Published As

Publication number Publication date
US10227301B2 (en) 2019-03-12
US20180155287A1 (en) 2018-06-07
JP2020100623A (ja) 2020-07-02
US20160194287A1 (en) 2016-07-07
EP3242869B1 (en) 2021-10-27
EP3242869A1 (en) 2017-11-15
NZ734324A (en) 2021-06-25
JP2022191331A (ja) 2022-12-27
US10343994B2 (en) 2019-07-09
CN110845355A (zh) 2020-02-28
SG11201705524SA (en) 2017-08-30
WO2016110865A1 (en) 2016-07-14
US20160207886A1 (en) 2016-07-21
US9464051B2 (en) 2016-10-11
ES2905771T3 (es) 2022-04-12
CN107428697A (zh) 2017-12-01
JP6679616B2 (ja) 2020-04-22
CA2973178C (en) 2022-11-01
CA2973178A1 (en) 2016-07-14
JP2018502915A (ja) 2018-02-01

Similar Documents

Publication Publication Date Title
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3386484T3 (da) Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
DK3212226T3 (da) Sammensætninger og anvendelsesfremgangsmåder til behandling af metaboliske lidelser
DK3206493T3 (da) Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
DK3206497T3 (da) Sammensætninger og fremgangsmåder til behandling af meibomsk kirtel-dysfunktion
DK3119797T3 (da) Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose
DK3185876T3 (da) Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser
DK3250210T3 (da) Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
DK3134130T3 (da) Sammensætninger og fremgangsmåder til behandling af hæmoglobinopatier
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK3277270T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3200815T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK3189074T3 (da) Sammensætninger og metoder til behandling og forebyggelse af inflammation
DK3007695T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK2994533T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
DK3394065T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf
DK3110446T3 (da) Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme
DK3367852T3 (da) Indretning og fremgangsmåde til behandling af levnedsmidler
DK3261644T3 (da) Sammensætninger og fremgangsmåder til behandling af nethindenedbrydning
DK3242947T3 (da) Genterapi og elektroporese til behandling af maligniteter
DK3102232T3 (da) Fremgangsmåder og sammensætninger til behandling af abnorm cellevækst
DK3319609T3 (da) Sammensætninger og fremgangsmåder til anvendelse af antibakterielle lægemiddelkombinationer
DK3310190T3 (da) Sammensætning til behandling af kød og anvendelse af denne
DK2830654T3 (da) Metoder og sammensætninger til behandling af inflammation